These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14596704)

  • 1. The potential contributions of chronic inflammation to lung carcinogenesis.
    Ballaz S; Mulshine JL
    Clin Lung Cancer; 2003 Jul; 5(1):46-62. PubMed ID: 14596704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
    Müller-Decker K
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
    Peebles KA; Lee JM; Mao JT; Hazra S; Reckamp KL; Krysan K; Dohadwala M; Heinrich EL; Walser TC; Cui X; Baratelli FE; Garon E; Sharma S; Dubinett SM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1405-21. PubMed ID: 17944566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evidence of the role of COX-2 in attenuating gastric inflammation and promoting gastric carcinogenesis.
    Hahm KB; Lim HY; Sohn S; Kwon HJ; Lee KM; Lee JS; Surh YJ; Kim YB; Joo HJ; Kim WS; Cho SW
    J Environ Pathol Toxicol Oncol; 2002; 21(2):165-76. PubMed ID: 12086403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS; Rao CV
    J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways for cancer chemoprevention by dietary phytochemicals.
    Tan AC; Konczak I; Sze DM; Ramzan I
    Nutr Cancer; 2011; 63(4):495-505. PubMed ID: 21500099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on cyclooxygenase-2 protein expression and vasculature during experimental rat lung carcinogenesis].
    Li HG; Yu LY; Liu MQ; Chen HL; Zhang YX; Liu X; Tang ZJ; Xia D; Zou ZY
    Ai Zheng; 2002 Jun; 21(6):605-9. PubMed ID: 12452059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitors in lung cancer.
    Ramalingam S; Belani CP
    Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifaceted roles of cyclooxygenase-2 in lung cancer.
    Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
    Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines.
    Dwyer-Nield LD; Srebernak MC; Barrett BS; Ahn J; Cosper P; Meyer AM; Kisley LR; Bauer AK; Thompson DC; Malkinson AM
    Carcinogenesis; 2005 Jul; 26(7):1196-206. PubMed ID: 15746162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
    Liao Z; Milas L
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic immune activation and inflammation as the cause of malignancy.
    O'Byrne KJ; Dalgleish AG
    Br J Cancer; 2001 Aug; 85(4):473-83. PubMed ID: 11506482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocotrienols: inflammation and cancer.
    Nesaretnam K; Meganathan P
    Ann N Y Acad Sci; 2011 Jul; 1229():18-22. PubMed ID: 21793834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.